Disparities in rates of peripheral diabetic neuropathy and lower extremity amputation exist in the United States. To investigate the factors linked to this disparity, we performed a systematic review ...
Lower extremity amputation risk was lower among users of SGLT-2 inhibitors vs DPP-4 inhibitors but higher among users of SGLT-2 inhibitors vs sulfonylureas. Among patients with type 2 diabetes, sodium ...
Peripheral artery disease (PAD) can lead to serious complications, including lower‑limb amputations. An updated interactive heat map showed PAD‑related amputation rates across the US, stratified by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results